シンデレラスリープボタニカルｆ

Registration number

K1102

Type

Processed food (tablets, capsules and similar forms)

Published status

Sales suspended

Notifier

株式会社ZERO PLUS

Notification date

2026-03-11

Modification date

2026-09-01

Notification under the company’s responsibility, without prior review by the Japanese state. The Japanese category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

• Information

  A claim declared in Japan is not an authorised health claim in the European Union.

  CAA, Japan Foods with Function Claims notifications, retrieval date unknown.

  Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

  Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Daily quantities are reproduced as declared, without estimation or conversion. A quantity is associated with an ingredient only when the name and match are unambiguous. Japanese names and texts are retained without translation. No comparison with dose limits is performed.

Name (original Japanese text)

ラフマ葉抽出物加工食品

Declared claim (original Japanese text)

本品には、ラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンが含まれます。ラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンには月経周期が正常な健常成人女性の月経前の一時的な晴れない気分の軽減と睡眠の質（起床時の睡眠に対する満足感）の向上に役立つことが報告されています。

Precautions (original Japanese text)

本品は多量摂取により疾病が治癒したり、より健康が増進したりするものではありません。一日の摂取目安量を守ってください。

Raw materials of functional ingredients (original Japanese text)

ラフマ葉抽出物

Recommended daily intake (original Japanese text)

2粒

Method of consumption (original Japanese text)

就寝前に、水又はぬるま湯などでお召し上がりください。

Ingredient names for daily quantities (original Japanese text)

ラフマ由来ヒペロシド、 ラフマ由来イソクエルシトリン

Declared daily quantities (original Japanese text)

ラフマ由来ヒペロシド　1mg、ラフマ由来イソクエルシトリン　1mg

A claim declared in Japan is not an authorised health claim in the European Union. See the health claims register.

Original register data

Official source

View the official register, number K1102

Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

List in the official revision dated 1 September 2026 (register: CAA, Japan Foods with Function Claims notifications).

Has the product changed? Photograph the packaging.